APO RESEARCH · REPORT
Head Lice Infestation Drug
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Product & engineering
Understand the product.
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Selected research
Industry Research
Head Lice Infestation Drug Industry Research Report 2026
Market perspective
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Scope
Read the full market overview
This report quantifies the global Head Lice Infestation Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Head Lice Infestation Drug Market by Company
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Head Lice Infestation Drug Segment by Type
Lotion
Creams
Shampoo
Other
Head Lice Infestation Drug Segment by Application
Children
Adult
Head Lice Infestation Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head Lice Infestation Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Head Lice Infestation Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head Lice Infestation Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Head Lice Infestation Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Head Lice Infestation Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lotion
- Creams
- Shampoo
- Other
Applications
- Children
- Adult
Companies covered
- Bayer
- Omega Pharma
- Thornton and Ross
- Prestige Brands
- Perrigo
- Actavis
- Reckitt Benckier
- Tyratech
- Shionogi
- TecLabs
- Arborpharma
- Major Pharmaceuticals
- Logic Products
- Tianren
- ParaPRO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Head Lice Infestation Drug Market Size (2021-2032)
- 2.2.2 Global Head Lice Infestation Drug Sales (2021-2032)
- 2.2.3 Global Head Lice Infestation Drug Market Average Price (2021-2032)
- 2.3 Head Lice Infestation Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lotion
- 2.3.3 Creams
- 2.3.4 Shampoo
- 2.3.5 Other
- 2.4 Head Lice Infestation Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Children
- 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Head Lice Infestation Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Head Lice Infestation Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Head Lice Infestation Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Head Lice Infestation Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Head Lice Infestation Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Head Lice Infestation Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Head Lice Infestation Drug, Product Type & Application
- 3.8 Global Manufacturers of Head Lice Infestation Drug, Established Date
- 3.9 Global Head Lice Infestation Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer
- 4.1.1 Bayer Company Information
- 4.1.2 Bayer Business Overview
- 4.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer Head Lice Infestation Drug Product Portfolio
- 4.1.5 Bayer Recent Developments
- 4.2 Omega Pharma
- 4.2.1 Omega Pharma Company Information
- 4.2.2 Omega Pharma Business Overview
- 4.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Omega Pharma Head Lice Infestation Drug Product Portfolio
- 4.2.5 Omega Pharma Recent Developments
- 4.3 Thornton and Ross
- 4.3.1 Thornton and Ross Company Information
- 4.3.2 Thornton and Ross Business Overview
- 4.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Thornton and Ross Head Lice Infestation Drug Product Portfolio
- 4.3.5 Thornton and Ross Recent Developments
- 4.4 Prestige Brands
- 4.4.1 Prestige Brands Company Information
- 4.4.2 Prestige Brands Business Overview
- 4.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Prestige Brands Head Lice Infestation Drug Product Portfolio
- 4.4.5 Prestige Brands Recent Developments
- 4.5 Perrigo
- 4.5.1 Perrigo Company Information
- 4.5.2 Perrigo Business Overview
- 4.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Head Lice Infestation Drug Product Portfolio
- 4.5.5 Perrigo Recent Developments
- 4.6 Actavis
- 4.6.1 Actavis Company Information
- 4.6.2 Actavis Business Overview
- 4.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Actavis Head Lice Infestation Drug Product Portfolio
- 4.6.5 Actavis Recent Developments
- 4.7 Reckitt Benckier
- 4.7.1 Reckitt Benckier Company Information
- 4.7.2 Reckitt Benckier Business Overview
- 4.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Reckitt Benckier Head Lice Infestation Drug Product Portfolio
- 4.7.5 Reckitt Benckier Recent Developments
- 4.8 Tyratech
- 4.8.1 Tyratech Company Information
- 4.8.2 Tyratech Business Overview
- 4.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Tyratech Head Lice Infestation Drug Product Portfolio
- 4.8.5 Tyratech Recent Developments
- 4.9 Shionogi
- 4.9.1 Shionogi Company Information
- 4.9.2 Shionogi Business Overview
- 4.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shionogi Head Lice Infestation Drug Product Portfolio
- 4.9.5 Shionogi Recent Developments
- 4.10 TecLabs
- 4.10.1 TecLabs Company Information
- 4.10.2 TecLabs Business Overview
- 4.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 TecLabs Head Lice Infestation Drug Product Portfolio
- 4.10.5 TecLabs Recent Developments
- 4.11 Arborpharma
- 4.11.1 Arborpharma Company Information
- 4.11.2 Arborpharma Business Overview
- 4.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Arborpharma Head Lice Infestation Drug Product Portfolio
- 4.11.5 Arborpharma Recent Developments
- 4.12 Major Pharmaceuticals
- 4.12.1 Major Pharmaceuticals Company Information
- 4.12.2 Major Pharmaceuticals Business Overview
- 4.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio
- 4.12.5 Major Pharmaceuticals Recent Developments
- 4.13 Logic Products
- 4.13.1 Logic Products Company Information
- 4.13.2 Logic Products Business Overview
- 4.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Logic Products Head Lice Infestation Drug Product Portfolio
- 4.13.5 Logic Products Recent Developments
- 4.14 Tianren
- 4.14.1 Tianren Company Information
- 4.14.2 Tianren Business Overview
- 4.14.3 Tianren Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Tianren Head Lice Infestation Drug Product Portfolio
- 4.14.5 Tianren Recent Developments
- 4.15 ParaPRO
- 4.15.1 ParaPRO Company Information
- 4.15.2 ParaPRO Business Overview
- 4.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 ParaPRO Head Lice Infestation Drug Product Portfolio
- 4.15.5 ParaPRO Recent Developments
5 Global Head Lice Infestation Drug Market Scenario by Region
- 5.1 Global Head Lice Infestation Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Head Lice Infestation Drug Sales by Region: 2021-2032
- 5.2.1 Global Head Lice Infestation Drug Sales by Region: 2021-2026
- 5.2.2 Global Head Lice Infestation Drug Sales by Region: 2027-2032
- 5.3 Global Head Lice Infestation Drug Revenue by Region: 2021-2032
- 5.3.1 Global Head Lice Infestation Drug Revenue by Region: 2021-2026
- 5.3.2 Global Head Lice Infestation Drug Revenue by Region: 2027-2032
- 5.4 North America Head Lice Infestation Drug Market Facts & Figures by Country
- 5.4.1 North America Head Lice Infestation Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Head Lice Infestation Drug Sales by Country (2021-2032)
- 5.4.3 North America Head Lice Infestation Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Head Lice Infestation Drug Market Facts & Figures by Country
- 5.5.1 Europe Head Lice Infestation Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Head Lice Infestation Drug Sales by Country (2021-2032)
- 5.5.3 Europe Head Lice Infestation Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Head Lice Infestation Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Head Lice Infestation Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Head Lice Infestation Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Head Lice Infestation Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Head Lice Infestation Drug Market Facts & Figures by Country
- 5.7.1 South America Head Lice Infestation Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Head Lice Infestation Drug Sales by Country (2021-2032)
- 5.7.3 South America Head Lice Infestation Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Head Lice Infestation Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Head Lice Infestation Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Head Lice Infestation Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Head Lice Infestation Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Head Lice Infestation Drug Sales by Type (2021-2032)
- 6.1.1 Global Head Lice Infestation Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Head Lice Infestation Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Head Lice Infestation Drug Revenue by Type (2021-2032)
- 6.2.1 Global Head Lice Infestation Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Head Lice Infestation Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Head Lice Infestation Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Head Lice Infestation Drug Sales by Application (2021-2032)
- 7.1.1 Global Head Lice Infestation Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Head Lice Infestation Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Head Lice Infestation Drug Revenue by Application (2021-2032)
- 7.2.1 Global Head Lice Infestation Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Head Lice Infestation Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Head Lice Infestation Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Head Lice Infestation Drug Value Chain Analysis
- 8.1.1 Head Lice Infestation Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Head Lice Infestation Drug Production Mode & Process
- 8.2 Head Lice Infestation Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Head Lice Infestation Drug Distributors
- 8.2.3 Head Lice Infestation Drug Customers
9 Global Head Lice Infestation Drug Analyzing Market Dynamics
- 9.1 Head Lice Infestation Drug Industry Trends
- 9.2 Head Lice Infestation Drug Industry Drivers
- 9.3 Head Lice Infestation Drug Industry Opportunities and Challenges
- 9.4 Head Lice Infestation Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst